Loading clinical trials...
Loading clinical trials...
A Randomized, Open Label, Controlled Study About Endostar Continued Pumping or Injecting Into Vein Combining With Gemcitabine-Carboplatin Versus Gemcitabine-Carboplatin Alone to Treat Non-Small Cell Lung Cancer (NSCLC)
Conditions
Interventions
Gemcitabine,Carboplatin,Endostar
Gemcitabine(G) Carboplatin(C) Endostar
+1 more
Locations
1
China
HuNan province tumor hospital
Changsha, Hunan, China
Start Date
August 1, 2011
Primary Completion Date
July 1, 2016
Completion Date
October 1, 2016
Last Updated
March 24, 2015
NCT06305754
NCT07190248
NCT07100080
NCT07195695
NCT06357533
NCT06731413
Lead Sponsor
Hunan Province Tumor Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions